KR20230067053A - cosmetic composition for skin whitening and antiwrinkle - Google Patents
cosmetic composition for skin whitening and antiwrinkle Download PDFInfo
- Publication number
- KR20230067053A KR20230067053A KR1020210152726A KR20210152726A KR20230067053A KR 20230067053 A KR20230067053 A KR 20230067053A KR 1020210152726 A KR1020210152726 A KR 1020210152726A KR 20210152726 A KR20210152726 A KR 20210152726A KR 20230067053 A KR20230067053 A KR 20230067053A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- weight
- cosmetic composition
- whitening
- wrinkle
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 69
- 239000002537 cosmetic Substances 0.000 title claims abstract description 53
- 230000002087 whitening effect Effects 0.000 title claims abstract description 25
- 230000001153 anti-wrinkle effect Effects 0.000 title claims description 15
- 239000000284 extract Substances 0.000 claims abstract description 148
- 230000003078 antioxidant effect Effects 0.000 claims abstract description 27
- 241000241413 Propolis Species 0.000 claims abstract description 25
- 229940069949 propolis Drugs 0.000 claims abstract description 25
- 240000007551 Boswellia serrata Species 0.000 claims abstract description 21
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 21
- 235000018062 Boswellia Nutrition 0.000 claims abstract description 20
- 235000014443 Pyrus communis Nutrition 0.000 claims abstract description 19
- 230000003110 anti-inflammatory effect Effects 0.000 claims abstract description 16
- 230000006870 function Effects 0.000 claims abstract description 12
- 229940013712 pineapple extract Drugs 0.000 claims abstract description 12
- 240000003152 Rhus chinensis Species 0.000 claims abstract description 11
- 235000014220 Rhus chinensis Nutrition 0.000 claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 28
- 238000000605 extraction Methods 0.000 claims description 23
- 239000002131 composite material Substances 0.000 claims description 19
- 239000000686 essence Substances 0.000 claims description 19
- 238000009472 formulation Methods 0.000 claims description 18
- -1 pack Substances 0.000 claims description 14
- 238000002156 mixing Methods 0.000 claims description 12
- 229940062002 zucchini extract Drugs 0.000 claims description 11
- 239000002904 solvent Substances 0.000 claims description 10
- 239000006210 lotion Substances 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 7
- 150000005846 sugar alcohols Polymers 0.000 claims description 7
- 239000006071 cream Substances 0.000 claims description 5
- 239000000344 soap Substances 0.000 claims description 5
- 125000004432 carbon atom Chemical group C* 0.000 claims description 4
- 239000006260 foam Substances 0.000 claims description 4
- 239000002453 shampoo Substances 0.000 claims description 4
- 150000001298 alcohols Chemical class 0.000 claims description 3
- 229940055350 kiwi fruit extract Drugs 0.000 claims description 3
- 240000006162 Chenopodium quinoa Species 0.000 claims description 2
- 241000219130 Cucurbita pepo subsp. pepo Species 0.000 claims description 2
- 235000003954 Cucurbita pepo var melopepo Nutrition 0.000 claims description 2
- 235000009434 Actinidia chinensis Nutrition 0.000 abstract description 12
- 239000003963 antioxidant agent Substances 0.000 abstract description 9
- 230000037303 wrinkles Effects 0.000 abstract description 9
- 239000000463 material Substances 0.000 abstract description 7
- 244000298715 Actinidia chinensis Species 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 47
- 238000012360 testing method Methods 0.000 description 23
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 22
- 241000220324 Pyrus Species 0.000 description 18
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 16
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 16
- 210000003491 skin Anatomy 0.000 description 16
- 230000000694 effects Effects 0.000 description 15
- 239000003921 oil Substances 0.000 description 15
- 235000019198 oils Nutrition 0.000 description 15
- 244000298697 Actinidia deliciosa Species 0.000 description 14
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 14
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 12
- 210000004027 cell Anatomy 0.000 description 11
- 235000011187 glycerol Nutrition 0.000 description 11
- 235000013399 edible fruits Nutrition 0.000 description 10
- 235000007119 Ananas comosus Nutrition 0.000 description 9
- 239000003755 preservative agent Substances 0.000 description 9
- 239000008213 purified water Substances 0.000 description 9
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 8
- 206010040880 Skin irritation Diseases 0.000 description 8
- 235000006708 antioxidants Nutrition 0.000 description 8
- 229960000271 arbutin Drugs 0.000 description 8
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 8
- 231100000475 skin irritation Toxicity 0.000 description 8
- 230000036556 skin irritation Effects 0.000 description 8
- 239000007788 liquid Substances 0.000 description 7
- 239000000049 pigment Substances 0.000 description 7
- 244000099147 Ananas comosus Species 0.000 description 6
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 229960005305 adenosine Drugs 0.000 description 6
- 238000003556 assay Methods 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- SNPLKNRPJHDVJA-UHFFFAOYSA-N dl-panthenol Chemical compound OCC(C)(C)C(O)C(=O)NCCCO SNPLKNRPJHDVJA-UHFFFAOYSA-N 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 238000000855 fermentation Methods 0.000 description 6
- 230000004151 fermentation Effects 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 5
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 5
- 206010015150 Erythema Diseases 0.000 description 5
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 5
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 5
- 229920002125 Sokalan® Polymers 0.000 description 5
- 102000003425 Tyrosinase Human genes 0.000 description 5
- 108060008724 Tyrosinase Proteins 0.000 description 5
- 238000002835 absorbance Methods 0.000 description 5
- 229960003237 betaine Drugs 0.000 description 5
- 229960001631 carbomer Drugs 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 231100000321 erythema Toxicity 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 230000006872 improvement Effects 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 239000004615 ingredient Substances 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 210000002752 melanocyte Anatomy 0.000 description 5
- 239000013641 positive control Substances 0.000 description 5
- 230000002335 preservative effect Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 208000003351 Melanosis Diseases 0.000 description 4
- 208000012641 Pigmentation disease Diseases 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000000835 fiber Substances 0.000 description 4
- 229960005323 phenoxyethanol Drugs 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 3
- 241000234671 Ananas Species 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 241000186427 Cutibacterium acnes Species 0.000 description 3
- 241000588724 Escherichia coli Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 3
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 241000235070 Saccharomyces Species 0.000 description 3
- 229920002385 Sodium hyaluronate Polymers 0.000 description 3
- 241000191963 Staphylococcus epidermidis Species 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 229940081733 cetearyl alcohol Drugs 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 231100000135 cytotoxicity Toxicity 0.000 description 3
- 230000003013 cytotoxicity Effects 0.000 description 3
- 210000002615 epidermis Anatomy 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 235000021121 fermented vegetables Nutrition 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 3
- 230000003834 intracellular effect Effects 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- 230000019612 pigmentation Effects 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 229940010747 sodium hyaluronate Drugs 0.000 description 3
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- 239000000454 talc Substances 0.000 description 3
- 229910052623 talc Inorganic materials 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- ZTOJFFHGPLIVKC-YAFCTCPESA-N (2e)-3-ethyl-2-[(z)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound S\1C2=CC(S(O)(=O)=O)=CC=C2N(CC)C/1=N/N=C1/SC2=CC(S(O)(=O)=O)=CC=C2N1CC ZTOJFFHGPLIVKC-YAFCTCPESA-N 0.000 description 2
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 2
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical group OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- NBGQZFQREPIKMG-UHFFFAOYSA-N 3beta-hydroxy-beta-boswellic acid Natural products C1CC(O)C(C)(C(O)=O)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CCC3C21C NBGQZFQREPIKMG-UHFFFAOYSA-N 0.000 description 2
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000416162 Astragalus gummifer Species 0.000 description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 2
- NBGQZFQREPIKMG-PONOSELZSA-N Boswellic acid Chemical compound C1C[C@@H](O)[C@](C)(C(O)=O)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C NBGQZFQREPIKMG-PONOSELZSA-N 0.000 description 2
- 206010008570 Chloasma Diseases 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 206010014970 Ephelides Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- 238000000134 MTT assay Methods 0.000 description 2
- 101800001751 Melanocyte-stimulating hormone alpha Proteins 0.000 description 2
- 240000007817 Olea europaea Species 0.000 description 2
- 102000016387 Pancreatic elastase Human genes 0.000 description 2
- 108010067372 Pancreatic elastase Proteins 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 102000035195 Peptidases Human genes 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 229920001214 Polysorbate 60 Polymers 0.000 description 2
- 102100027467 Pro-opiomelanocortin Human genes 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 229920001615 Tragacanth Polymers 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 238000003915 air pollution Methods 0.000 description 2
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 2
- SNAAJJQQZSMGQD-UHFFFAOYSA-N aluminum magnesium Chemical compound [Mg].[Al] SNAAJJQQZSMGQD-UHFFFAOYSA-N 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- SESFRYSPDFLNCH-UHFFFAOYSA-N benzyl benzoate Chemical compound C=1C=CC=CC=1C(=O)OCC1=CC=CC=C1 SESFRYSPDFLNCH-UHFFFAOYSA-N 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 229940008099 dimethicone Drugs 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000019197 fats Nutrition 0.000 description 2
- 229940075529 glyceryl stearate Drugs 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- DWMMZQMXUWUJME-UHFFFAOYSA-N hexadecyl octanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)CCCCCCC DWMMZQMXUWUJME-UHFFFAOYSA-N 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 239000001630 malic acid Substances 0.000 description 2
- 235000011090 malic acid Nutrition 0.000 description 2
- 230000008099 melanin synthesis Effects 0.000 description 2
- 210000002780 melanosome Anatomy 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- VMGAPWLDMVPYIA-HIDZBRGKSA-N n'-amino-n-iminomethanimidamide Chemical compound N\N=C\N=N VMGAPWLDMVPYIA-HIDZBRGKSA-N 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 206010033675 panniculitis Diseases 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 239000002953 phosphate buffered saline Substances 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 2
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 2
- 229940113124 polysorbate 60 Drugs 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- BOLDJAUMGUJJKM-LSDHHAIUSA-N renifolin D Natural products CC(=C)[C@@H]1Cc2c(O)c(O)ccc2[C@H]1CC(=O)c3ccc(O)cc3O BOLDJAUMGUJJKM-LSDHHAIUSA-N 0.000 description 2
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 230000009759 skin aging Effects 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 2
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 210000004304 subcutaneous tissue Anatomy 0.000 description 2
- 239000000196 tragacanth Substances 0.000 description 2
- 235000010487 tragacanth Nutrition 0.000 description 2
- 229940116362 tragacanth Drugs 0.000 description 2
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 2
- 229940096998 ursolic acid Drugs 0.000 description 2
- 235000013311 vegetables Nutrition 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- WHNFPRLDDSXQCL-UAZQEYIDSA-N α-msh Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)NC(=O)[C@H](CO)NC(C)=O)C1=CC=C(O)C=C1 WHNFPRLDDSXQCL-UAZQEYIDSA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- AAWZDTNXLSGCEK-LNVDRNJUSA-N (3r,5r)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid Chemical compound O[C@@H]1CC(O)(C(O)=O)C[C@@H](O)C1O AAWZDTNXLSGCEK-LNVDRNJUSA-N 0.000 description 1
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- 238000010269 ABTS assay Methods 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 235000009051 Ambrosia paniculata var. peruviana Nutrition 0.000 description 1
- 241001124076 Aphididae Species 0.000 description 1
- 235000003097 Artemisia absinthium Nutrition 0.000 description 1
- 240000001851 Artemisia dracunculus Species 0.000 description 1
- 235000017731 Artemisia dracunculus ssp. dracunculus Nutrition 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 235000003717 Boswellia sacra Nutrition 0.000 description 1
- 235000012035 Boswellia serrata Nutrition 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 108010004032 Bromelains Proteins 0.000 description 1
- 241000234670 Bromeliaceae Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- AAWZDTNXLSGCEK-UHFFFAOYSA-N Cordycepinsaeure Natural products OC1CC(O)(C(O)=O)CC(O)C1O AAWZDTNXLSGCEK-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012442 Dermatitis contact Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 239000004863 Frankincense Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 244000144994 Galla Rhois Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 229920002488 Hemicellulose Polymers 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000257303 Hymenoptera Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010065390 Inflammatory pain Diseases 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 231100000002 MTT assay Toxicity 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920000289 Polyquaternium Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 241000219295 Portulaca Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- AAWZDTNXLSGCEK-ZHQZDSKASA-N Quinic acid Natural products O[C@H]1CC(O)(C(O)=O)C[C@H](O)C1O AAWZDTNXLSGCEK-ZHQZDSKASA-N 0.000 description 1
- 244000097577 Rhus javanica Species 0.000 description 1
- 235000010889 Rhus javanica Nutrition 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 208000006981 Skin Abnormalities Diseases 0.000 description 1
- 206010040914 Skin reaction Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 241000543664 Triglochin maritima Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 241000235033 Zygosaccharomyces rouxii Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- ZTOJFFHGPLIVKC-CLFAGFIQSA-N abts Chemical compound S/1C2=CC(S(O)(=O)=O)=CC=C2N(CC)C\1=N\N=C1/SC2=CC(S(O)(=O)=O)=CC=C2N1CC ZTOJFFHGPLIVKC-CLFAGFIQSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000001760 anti-analgesic effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 239000001138 artemisia absinthium Substances 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000002012 ayurvedic medicine Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229960002903 benzyl benzoate Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 235000019835 bromelain Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 238000006388 chemical passivation reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 208000037976 chronic inflammation Diseases 0.000 description 1
- 230000006020 chronic inflammation Effects 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 1
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 208000010247 contact dermatitis Diseases 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- 231100000263 cytotoxicity test Toxicity 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 229940124568 digestive agent Drugs 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- VJNCICVKUHKIIV-UHFFFAOYSA-N dopachrome Chemical compound O=C1C(=O)C=C2NC(C(=O)O)CC2=C1 VJNCICVKUHKIIV-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000008387 emulsifying waxe Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- LYCAIKOWRPUZTN-UHFFFAOYSA-N ethylene glycol Natural products OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000007760 free radical scavenging Effects 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 239000000017 hydrogel Substances 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 239000001573 invertase Substances 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- LDHBWEYLDHLIBQ-UHFFFAOYSA-M iron(3+);oxygen(2-);hydroxide;hydrate Chemical compound O.[OH-].[O-2].[Fe+3] LDHBWEYLDHLIBQ-UHFFFAOYSA-M 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000002540 macrophage Anatomy 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000036564 melanin content Effects 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- NDLPOXTZKUMGOV-UHFFFAOYSA-N oxo(oxoferriooxy)iron hydrate Chemical compound O.O=[Fe]O[Fe]=O NDLPOXTZKUMGOV-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 235000021017 pears Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229940055019 propionibacterium acne Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 239000001944 prunus armeniaca kernel oil Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 210000003079 salivary gland Anatomy 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- 230000008591 skin barrier function Effects 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000035483 skin reaction Effects 0.000 description 1
- 231100000430 skin reaction Toxicity 0.000 description 1
- 230000036560 skin regeneration Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229960005322 streptomycin Drugs 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 150000003573 thiols Chemical class 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 229940074410 trehalose Drugs 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000037373 wrinkle formation Effects 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
- A61K8/988—Honey; Royal jelly, Propolis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Zoology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은 미백 및 주름개선 기능을 갖는 화장료 조성물에 관한 것으로서, 더욱 상세하게는 천연의 소재들을 이용하여 미백 및 주름개선, 항산화 효과, 항염 효과, 항균 효과가 우수한 기능성 화장료 조성물에 관한 것이다. The present invention relates to a cosmetic composition having whitening and anti-wrinkle functions, and more particularly, to a functional cosmetic composition having excellent whitening and anti-wrinkle, antioxidant, anti-inflammatory, and antibacterial effects using natural materials.
피부는 신체 중 가장 큰 기관으로 항상 외부환경과 직접 접하고 있으면서 여러 가지 자극이나 건조한 환경으로부터 생체를 보호하는 보호막의 역할을 하고 있으며, 다른 기관에 비하여 새로운 세포의 생성과 소멸이 활발히 일어나는 기관이다. 또한, 물리적인 찰과상으로부터 신체를 보호하고, 신체 내부의 수분의 손실을 막아주며 태양에서 발생되는 자외선으로부터 보호해주고, 몸의 체온을 조절해주는 데 매우 중요한 역할을 담당하고 있다.The skin is the largest organ in the body, always in direct contact with the external environment, and plays a role as a protective film to protect the living body from various stimuli or dry environments. In addition, it plays a very important role in protecting the body from physical abrasions, preventing loss of moisture inside the body, protecting from ultraviolet rays generated by the sun, and regulating body temperature.
이러한 피부는 여러 가지 물리적 요인, 외부환경적 요인, 감염 등으로 인해 피부의 오염과 건조, 트러블, 색소 침착 등의 피부이상을 가져오며 결국 피부염이나 알러지 발생 및 악화를 야기한다. Such skin causes skin abnormalities such as skin contamination, dryness, trouble, and pigmentation due to various physical factors, external environmental factors, and infections, and eventually causes dermatitis or allergy to occur and deteriorate.
이러한 피부 조직은 크게 3가지 부분 즉, 표피, 진피 및 피하조직으로 나누어진다. 사람의 피부색은 주로 피부세포 속에 함유되어 있는 멜라닌을 함유하는 멜라노좀의 숫자, 크기, 종류 및 분포도에 따라 다르게 나타난다. 멜라노좀은 멜라닌 세포에 의해 생성되며, 멜라닌은 표피에서 생성되는 검은 색소이고 멜라노사이트라는 세포에서 생산된다. This skin tissue is largely divided into three parts, that is, epidermis, dermis and subcutaneous tissue. Human skin color appears differently depending on the number, size, type, and distribution of melanosomes containing melanin contained in skin cells. Melanosomes are produced by melanocytes, and melanin is a black pigment produced in the epidermis and is produced in cells called melanocytes.
사람의 피부색을 결정하는 데는 여러 요인들이 관여하는데, 그 중에서도 멜라닌 색소를 만드는 멜라노사이트의 활동성, 혈관의 분포, 피부의 두께 및 카로티노이드, 빌리루빈 등의 인체 내외의 색소 함유 유무 등의 요인들이 중요하다. 특히, 가장 중요한 요인은 인체 내의 멜라노사이트에서 티로시나제 등의 여러 효소가 작용하여 생성되는 멜라닌이라는 흑색 색소이다. 이 멜라닌 색소의 형성에는 유전적 요인, 호르몬 분비, 스트레스 등과 관련된 생리적 요인 및 자외선 조사 등과 같은 환경적 요인 등이 영향을 미친다. 그러나 멜라닌 색소의 과다한 생성 및 침착은 피부의 흑화, 기미, 주근깨, 색소 침착 등과 같은 피부 색소 이상 침착 등의 피부 질환을 유발한다.Various factors are involved in determining the skin color of a person. Among them, factors such as the activity of melanocytes that produce melanin pigment, the distribution of blood vessels, the thickness of the skin, and the presence or absence of pigments inside and outside the human body such as carotenoids and bilirubin are important. In particular, the most important factor is a black pigment called melanin, which is produced by the action of various enzymes such as tyrosinase in melanocytes in the human body. The formation of this melanin pigment is influenced by genetic factors, hormone secretion, physiological factors related to stress, and the like, and environmental factors such as ultraviolet irradiation. However, excessive production and deposition of melanin pigment causes skin diseases such as darkening of the skin, melasma, freckles, and abnormal skin pigmentation such as pigmentation.
그리고 피부는 나이가 들면서 표피, 진피 및 피하조직의 두께가 얇아져 피부 장벽 기능이 저하되고 피부의 수분 함량의 급격한 감소로 피부가 건조해지는 등 피부의 생리적 기능이 저하되고, 이로 인한 다양한 변화가 오면서 노화된다. 특히, 자외선량의 증가와 대기오염 및 현대인의 과도한 피로와 스트레스 등으로 인해 생성되는 반응성이 높은 활성 산소와 자유 라디칼은 생체성분 (예, 단백질, 핵산, 세포막 지질 등)을 산화시키거나 변성시킴으로써, 피부노화의 주원인으로 작용한다. 따라서, 피부노화에 따른 주름형성, 피부탄력 감소, 색소침착, 기미, 주근깨 및 건조 등을 예방 및 치료하기 위한 다양한 기능성 화장품들이 개발되고 있다. In addition, as the skin ages, the thickness of the epidermis, dermis, and subcutaneous tissue becomes thinner, and the skin barrier function deteriorates. do. In particular, highly reactive active oxygen and free radicals generated due to the increase in the amount of ultraviolet rays, air pollution, and excessive fatigue and stress of modern people oxidize or denature biological components (eg, proteins, nucleic acids, cell membrane lipids, etc.), It acts as a major cause of skin aging. Therefore, various functional cosmetics are being developed to prevent and treat wrinkle formation, skin elasticity reduction, pigmentation, melasma, freckles and dryness due to skin aging.
최근에 급격한 경제 발전으로 인한 소득 증가는 삶의 질을 향상시키고 있으나, 산업화로 인하여 공기오염과 환경오염으로 피부에 자극을 나타낼 위험성이 점차 증가하고 있다. 이러한 이유로 건강한 피부에 대한 관심이 증가하고 있다. 건강하고 아름다운 피부를 원하는 소비자의 구매 의향을 따라서 친환경적, 자연 유래의 원료로 만든 천연 화장품을 선호하는 추세이다. 천연 유래의 기능성 화장품은 일반 화장품 보다 기능성 및 안전성에 대하여 강조되고 있다. Recently, an increase in income due to rapid economic development has improved the quality of life, but due to industrialization, the risk of skin irritation due to air pollution and environmental pollution is gradually increasing. For this reason, interest in healthy skin is increasing. There is a trend toward eco-friendly and natural cosmetics made from natural ingredients according to the purchasing intention of consumers who want healthy and beautiful skin. Functional cosmetics of natural origin are more emphasized on functionality and safety than general cosmetics.
대한민국 공개특허 제10-2018-0123831호, 대한민국 공개특허 제10-2019-0093283호, 대한민국 등록특허 제10-2021264호 등에 개시된 바와 같이 식물이나 해양생물 유래의 천연물이 다양한 형태로 화장품에 적용되고 있다. 특히, 현재 자연주의를 추구로 천연 생약 원료로 개발 및 제조한 천연화장품, 한방화장품이 트랜드를 선도하고 있다. 일반적으로 약용식물은 건강 증진 효과와 질병 예방 효과, 건강 개선에 효과적이다. As disclosed in Korean Patent Publication No. 10-2018-0123831, Korean Patent Publication No. 10-2019-0093283, and Korean Patent Registration No. 10-2021264, natural products derived from plants or marine organisms are applied to cosmetics in various forms. . In particular, natural cosmetics and herbal cosmetics developed and manufactured with natural herbal ingredients in pursuit of naturalism are leading the trend. In general, medicinal plants are effective in promoting health, preventing diseases, and improving health.
이에 따라 본 발명은 천연의 소재를 화장품의 원료로 활용하여 미백 및 주름개선, 항산화 효과, 항염 효과, 항균 효과를 가져 기능성이 우수한 화장료 조성물을 제공하는 데 그 목적이 있다. Accordingly, an object of the present invention is to provide a functional cosmetic composition having whitening and wrinkle improvement, antioxidant effect, anti-inflammatory effect, and antibacterial effect by utilizing natural materials as raw materials of cosmetics.
상기의 목적을 달성하기 위한 본 발명의 미백 및 주름개선 기능을 갖는 화장료 조성물은 프로폴리스 추출물, 오배자 추출물, 보스웰리아 추출물, 파인애플 추출물, 참다래 추출물, 배 추출물을 혼합한 복합추출물을 함유한다. The cosmetic composition having whitening and anti-wrinkle functions of the present invention for achieving the above object contains a complex extract in which propolis extract, gall nut extract, boswellia extract, pineapple extract, kiwi extract, and pear extract are mixed.
상기 각 추출물은 추출용매를 가하여 추출하고, 상기 추출용매는 물, 탄소수 1 내지 4의 저급 알코올, 다가 알코올 또는 이들의 혼합물로부터 선택된 적어도 어느 하나이다. Each extract is extracted by adding an extraction solvent, and the extraction solvent is at least one selected from water, lower alcohols having 1 to 4 carbon atoms, polyhydric alcohols, or mixtures thereof.
상기 복합추출물은 상기 프로폴리스 추출물 100중량부에 대하여 상기 오배자 추출물 45 내지 55중량부, 상기 보스웰리아 추출물 35 내지 45중량부, 상기 파인애플 추출물 20 내지 30중량부, 상기 참다래 추출물 20 내지 30중량부, 상기 배 추출물 10 내지 15중량부가 혼합된다. The composite extract contains 45 to 55 parts by weight of the nut gall extract, 35 to 45 parts by weight of the Boswellia extract, 20 to 30 parts by weight of the pineapple extract, and 20 to 30 parts by weight of the kiwi extract, based on 100 parts by weight of the propolis extract. , 10 to 15 parts by weight of the pear extract is mixed.
상기 복합추출물은 항산화 활성을 갖는다. The composite extract has antioxidant activity.
상기 복합추출물은 항염 활성을 갖는다. The composite extract has anti-inflammatory activity.
상기 복합추출물은 항균 활성을 갖는다. The composite extract has antibacterial activity.
상기 화장료 조성물은 화장수, 로션, 크림, 에센스, 팩, 파우더, 메이컵베이스, 파운데이션, 바디오일, 바디로션, 클렌징오일, 클렌징폼, 헤어오일, 헤어샴프, 헤어린스, 비누 중에서 선택된 어느 하나의 제형으로 형성된다.The cosmetic composition is any one formulation selected from lotion, lotion, cream, essence, pack, powder, makeup base, foundation, body oil, body lotion, cleansing oil, cleansing foam, hair oil, hair shampoo, hair rinse, and soap is formed by
지채의 잎을 발효시켜 추출한 지채 발효추출물을 더 함유한다. It further contains a fermented vegetable extract extracted by fermenting the leaves of the vegetable.
상술한 바와 같이 본 발명은 천연소재인 프로폴리스, 오배자, 보스웰리아, 파인애플, 참다래, 배를 화장품의 소재로 활용함으로써 안전하면서도 기능성이 우수한 화장료 조성물을 제공할 수 있다. As described above, the present invention can provide a cosmetic composition that is safe and has excellent functionality by using natural materials such as propolis, gall nut, boswellia, pineapple, kiwi, and pear as materials for cosmetics.
본 발명의 화장료 조성물은 프로폴리스, 오배자, 보스웰리아, 파인애플, 참다래, 배의 추출물을 혼합한 복합추출물을 함유하여 미백 및 주름개선, 항산화 효과, 항염 효과, 항균 효과가 우수하다. The cosmetic composition of the present invention contains a complex extract obtained by mixing extracts of propolis, nut gall, boswellia, pineapple, quinoa, and pear, and has excellent whitening and anti-wrinkle effects, antioxidant effects, anti-inflammatory effects, and antibacterial effects.
도 1 및 도2는 항산화활성 실험결과를 나타낸 그래프이고,
도 3 및 도 4는 미백활성 실험결과를 나타낸 그래프이고,
도 5 및 도 6은 세포독성 실험결과를 나타낸 그래프이고,
도 7은 주름개선 실험결과를 나타낸 그래프이고,
도 8은 항염 실험결과를 나타낸 그래프이고,
도 9 및 도 10은 추가적인 항산화활성 실험결과를 나타낸 그래프이다. 1 and 2 are graphs showing the antioxidant activity test results,
3 and 4 are graphs showing the whitening activity test results,
5 and 6 are graphs showing the results of cytotoxicity experiments;
7 is a graph showing the results of wrinkle improvement experiments;
8 is a graph showing the anti-inflammatory test results,
9 and 10 are graphs showing additional antioxidant activity test results.
이하, 본 발명의 바람직한 실시 예에 따른 미백 및 주름개선 기능을 갖는 화장료 조성물에 대하여 구체적으로 설명한다. Hereinafter, a cosmetic composition having whitening and anti-wrinkle functions according to a preferred embodiment of the present invention will be described in detail.
본 발명의 화장료 조성물은 프로폴리스 추출물, 오배자 추출물, 보스웰리아 추출물, 파인애플 추출물, 참다래 추출물, 배 추출물을 혼합한 복합추출물을 함유한다. The cosmetic composition of the present invention contains a complex extract in which propolis extract, gall nut extract, boswellia extract, pineapple extract, kiwi extract, and pear extract are mixed.
프로폴리스(propolis)는 벌들이 침샘 분비물과 나무, 꽃, 잎 등으로부터 수집하는 밀랍과 수지 물질을 혼합하여 만든 물질로서, 박테리아 또는 바이러스 감염으로부터 집을 보호하는 용도로 사용한다. Propolis is a substance made by mixing beeswax and resin substances collected by bees from salivary gland secretions and trees, flowers, leaves, etc., and is used to protect houses from bacterial or viral infections.
프로폴리스는 약 200가지 화합물과 플라보노이드, 미네랄, 비타민, 아미노산, 지방, 유기산 등으로 이루어져 있다. 이중 플라보노이드는 식물의 줄기 및 꽃의 여러 부분에 함유되어 있으며, 담황색과 노란색을 띠고 있는 페놀계 화합물이다. 플라보노이드는 생체내의 면역력을 증강시키며 항바이러스, 항암 등의 생리활성 기능을 나타내는 프로폴리스의 가장 중요한 성분으로 알려져 있다. Propolis consists of about 200 compounds, flavonoids, minerals, vitamins, amino acids, fats, and organic acids. Among them, flavonoids are contained in various parts of plant stems and flowers, and are light yellow and yellow phenolic compounds. Flavonoids are known as the most important component of propolis that enhances immunity in vivo and exhibits physiologically active functions such as antiviral and anticancer properties.
오배자(Galla rhois)는 옻나무과에 속한 낙엽소교목인 붉나무(Rhus javanica L.) 또는 그 밖의 동속 식물의 잎에 오배자 진딧물의 자상에 의하여 생긴 벌레집이다. 주요성분인 탄닌(tannin)의 함량이 높아 수렴작용에 의한 지사작용, 항균작용, 선 분비 억제작용을 나타낸다. 오배자는 항균작용 및 항산화, 항혈전, 간보호 등 약리작용이 있는 것으로 보고되었다. Galla rhois is a deciduous arboretum belonging to the sumacaceae, a wormwood ( Rhus javanica L.) or an insect nest formed by the cuts of galla aphids on the leaves of other plants of the same genus. It has a high content of tannin, which is a major component, and shows antidiarrheal, antibacterial, and glandular secretion suppression effects by astringent action. Gallbladder has been reported to have pharmacological effects such as antibacterial, antioxidant, antithrombotic, and hepatoprotective effects.
보스웰리아(Boswellia)는 감람과에 속하는 유향나무의 수액을 건조시켜 만든 약재로서, 인도전통 아유르베다 의학서에 만성염증 및 관절염, 소염, 타박상, 호흡기 질환 및 설사 등에 사용하였다고 기록되어 있으며, 높은 소염 진통 효과로 진통 및 염증 치료에 지속적으로 사용되어 온 것으로 알려져 있다. 보스웰리아의 주요 성분은 보스웰릭산(boswellic acid)과 테르페노이드 형태의 항산화물질들로, 이중 보스웰릭산은 보스웰리아의 소염 및 진통 효과를 나타내는 기능 물질이다. Boswellia is a medicine made by drying the sap of the frankincense tree belonging to the Olive family. It is recorded in traditional Indian Ayurvedic medicine that it was used for chronic inflammation, arthritis, anti-inflammatory, bruises, respiratory diseases and diarrhea, and has high anti-inflammatory pain relief. It is known that it has been continuously used for pain relief and inflammation treatment due to its effectiveness. The main components of boswellia are boswellic acid and terpenoid-type antioxidants, among which boswellic acid is a functional substance that exhibits anti-inflammatory and analgesic effects of boswellia.
파인애플(Ananas comosus)은 파인애플과(Bromeliaceae)에 속하는 중앙 및 남아메리카를 원산지로 하는 과일이다. 파인애플 과육의 수분은 약 80~85%이며, 당분은 주로 설탕으로 과당과 포도당을 포함해서 12~15%이다. 또한 0.6~1.2%의 산을 포함하고 있는데 그 중에 약 87%가 구연산(citric acid)이고 나머지가 사과산(malic acid)이다. 그 밖에 단백질 약 0.5~1%, 지방 0.1% 및 약간의 섬유질, 칼슘, 인, 철분과 같은 무기물과 비타민 A, B, C 등을 함유하고 있다.Pineapple ( Ananas comosus ) is a fruit native to Central and South America belonging to the pineapple family (Bromeliaceae). The water content of pineapple flesh is about 80-85%, and sugar is mainly sugar, including fructose and glucose, which is 12-15%. It also contains 0.6-1.2% acid, of which about 87% is citric acid and the rest is malic acid. In addition, it contains about 0.5 to 1% of protein, 0.1% of fat, and some fiber, minerals such as calcium, phosphorus, and iron, and vitamins A, B, and C.
파인애플의 브로멜라인(bromelain)은 -SH기를 갖는 티올(thiol)계의 단백질분해효소로 중세시대부터 보조 소화제, 소염제로 이용되어 왔으며, 안전성이 매우 높아 부작용이나 독성이 없고 계속 사용하여도 신체 내에 내성이 생기지 않는 것으로 알려져 있다.Pineapple bromelain is a thiol-based proteolytic enzyme with -SH group. It has been used as an auxiliary digestive and anti-inflammatory agent since the Middle Ages. It is known that no tolerance develops.
키위로도 불리우는 참다래에는 vitamin C, vitamin E와 섬유소가 풍부하며, 나트륨이 적고 칼륨이 많아 고혈압 예방효과가 있다고 알려져 있다. 또한 참다래에는 quinic acid, malic acid, citric acid 등의 유기산이 다량 함유되어 있어 특유의 풍미를 지니고 있다. 단백질 분해효소가 들어 있어 가정이나 음식점에서 육류 요리에 참다래를 몇 조각 첨가하면 빛깔이 좋아지고 향기 또한 향상되며 육류 과다섭취로 일어나는 여러 가지 질병을 예방할 수가 있다고 알려져 있다. Kiwi, also called kiwi, is rich in vitamin C, vitamin E and fiber, and is known to have a high blood pressure preventive effect because it is low in sodium and high in potassium. In addition, quinic acid, malic acid, citric acid, etc. are contained in a large amount of organic acids, so it has a unique flavor. It contains proteolytic enzymes, so adding a few pieces of kiwi to meat dishes at home or in restaurants improves the color and aroma, and is known to prevent various diseases caused by excessive consumption of meat.
배(pear)는 배나무과속(Pyrus)에 속하는 낙엽고목 식물의 열매로 다른 과실에 비해 당도가 높고 무기성분이 많이 함유된 대표적인 알칼리성 식품이다. 인버타제, 옥시타제 함유 과피는 부스럼이나 피부질환에, 그리고 과실은 가래, 기침, 숙취, 해열, 배변, 연육 등에 쓰여왔다.Pear is a fruit of a deciduous plant belonging to the genus Pyrus, and is a representative alkaline food that has a higher sugar content than other fruits and contains a lot of inorganic components. The peel containing invertase and oxytase has been used for boils and skin diseases, and the fruit has been used for phlegm, cough, hangover, fever relief, bowel movements, and soft meat.
배의 세포벽은 셀룰로오스(cellulose), 헤미셀룰로오스(hemicellulose), 펙틴(pectin) 등의 다당류, 당단백질 및 미량의 페놀계 물질로 구성되어 있다. 배는 식이섬유 함량이 높아 정장작용이 탁월하며 기능성 성분인 페놀성 물질을 다량으로 함유하고 있어 항산화, 항암 및 항염증 효과가 뛰어난 것으로 알려져 있다. 또한 배의 폴리페놀은 혈중 콜레스테롤 저하, 면역기능 강화, 암세포의 생육억제 등이 우수한 것으로 보고되고 있다. The cell wall of the pear is composed of polysaccharides such as cellulose, hemicellulose, and pectin, glycoproteins, and trace amounts of phenolic substances. Pears are known to have excellent intestinal function due to their high dietary fiber content and have excellent antioxidant, anticancer and anti-inflammatory effects because they contain a large amount of phenolic substances, which are functional ingredients. In addition, pear polyphenols are reported to be excellent in lowering blood cholesterol, enhancing immune function, and inhibiting the growth of cancer cells.
상술한 천연소재인 프로폴리스, 오배자, 보스웰리아, 파인애플, 참다래, 배는 추출물 형태로 이용한다. The above-mentioned natural materials such as propolis, nut gall, boswellia, pineapple, kiwi, and pear are used in the form of extracts.
각 추출물은 추출용매를 가하여 수득할 수 있다. 이때 추출용매로 물, 탄소수 1 내지 4의 저급 알코올, 다가 알코올 또는 이들의 혼합물로부터 선택된 적어도 어느 하나를 이용할 수 있다. Each extract can be obtained by adding an extraction solvent. At this time, at least one selected from water, lower alcohols having 1 to 4 carbon atoms, polyhydric alcohols, or mixtures thereof may be used as the extraction solvent.
탄소수 1 내지 4의 저급 알코올로 메탄올, 에탄올 등을 이용할 수 있고, 다가 알코올로 부틸렌글리콜 및 프로필렌글리콜, 펜틸렌글리콜 등을 이용할 수 있다. 그리고 혼합물로는 물 및 저급 알코올의 혼합물, 물 및 다가 알코올의 혼합물, 저급 알코올 및 다가 알코올의 혼합물, 또는 물 및 저급알코올 및 다가 알코올의 혼합물을 이용할 수 있다. Methanol, ethanol, etc. can be used as a lower alcohol having 1 to 4 carbon atoms, and butylene glycol, propylene glycol, pentylene glycol, etc. can be used as a polyhydric alcohol. As the mixture, a mixture of water and a lower alcohol, a mixture of water and a polyhydric alcohol, a mixture of a lower alcohol and a polyhydric alcohol, or a mixture of water, a lower alcohol and a polyhydric alcohol may be used.
추출의 일 예로 각 천연소재에 대하여 추출용매를 중량비로 2 내지 20배로 가한 후 10 내지 150℃에서 2 내지 200시간 동안 열수추출, 냉침 또는 온침 추출 방법으로 추출할 수 있다. 추출의 구체적 일 예로 프로폴리스에 에탄올을 가해 30 내지 40℃에서 100 내지 140시간 동안 추출하여 프로폴리스 추출물을 수득할 수 있다. As an example of extraction, after adding an extraction solvent in a weight ratio of 2 to 20 times for each natural material, extraction may be performed by hot water extraction, cold extraction, or warm needle extraction at 10 to 150 ° C. for 2 to 200 hours. As a specific example of extraction, propolis extract may be obtained by adding ethanol to propolis and extracting at 30 to 40° C. for 100 to 140 hours.
그리고 상술한 추출방법 외에도 환류냉각추출, 초음파 추출방법 등을 이용하여 추출할 수 있다. 또한, 통상적인 정제 과정을 거친 추출물도 포함한다. 예컨대, 일정한 분자량 컷-오프 값을 갖는 한외여과막을 이용한 분리, 다양한 크로마토그래피에 의한 분리 등, 추가적으로 실시된 다양한 정제 방법을 통해 얻어진 활성 분획도 추출물에 포함되는 것이다.In addition to the above-mentioned extraction method, it can be extracted using reflux cooling extraction, ultrasonic extraction method, and the like. In addition, an extract subjected to a conventional purification process is also included. For example, an active fraction obtained through various additional purification methods, such as separation using an ultrafiltration membrane having a certain molecular weight cut-off value and separation by various chromatography, is also included in the extract.
또한, 추출용매를 이용하여 추출한 추출물을 여과, 감압농축 또는 동결건조, 분무건조 방식 등을 통해 분말 형태로 얻을 수 있음은 물론이다.In addition, of course, the extract extracted using the extraction solvent can be obtained in powder form through filtration, concentration under reduced pressure, freeze-drying, spray drying, or the like.
프로폴리스로부터 추출한 프로폴리스 추출물, 오배자로부터 추출한 오배자 추출물, 보스웰리아로부터 추출한 보스웰리아 추출물, 파인애플의 열매로부터 추출한 파인애플 추출물, 참다래의 열매로부터 추출한 참다래 추출물, 배의 열매로부터 추출한 배 추출물을 혼합하여 복합추출물을 얻는다.Propolis extract extracted from propolis, nut gall extract extracted from nut gall, boswellia extract extracted from boswellia, pineapple extract extracted from pineapple fruit, kiwi fruit extract extracted from kiwi fruit, and pear extract extracted from pear fruit were mixed. Get a complex extract.
이러한 복합추출물은 미백과 주름을 개선시킨다. 또한, 복합추출물은 항산화 활성, 항염 활성, 항균 활성을 갖는다. 따라서 복합추출물을 함유한 본 발명의 화장료 조성물은 기능성이 우수한 화장품을 제공할 수 있다. These complex extracts improve whitening and wrinkles. In addition, the complex extract has antioxidant activity, anti-inflammatory activity, and antibacterial activity. Therefore, the cosmetic composition of the present invention containing the composite extract can provide cosmetics with excellent functionality.
본 발명은 화장료 조성물 총 중량에 대하여 복합추출물을 0.01 내지 20중량%를 함유할 수 있다. 복합추출물의 함량이 0.01중량% 미만이면 미백 및 주름개선, 항산화 효과, 항염 효과, 항균 효과가 미미하고, 20중량%를 초과하게 되면 함량에 비해 상승된 효과를 가지기 어렵다.The present invention may contain 0.01 to 20% by weight of the composite extract based on the total weight of the cosmetic composition. If the content of the complex extract is less than 0.01% by weight, the whitening and wrinkle improvement, antioxidant effect, anti-inflammatory effect, and antibacterial effect are insignificant, and when it exceeds 20% by weight, it is difficult to have an increased effect compared to the content.
본 발명의 화장료 조성물은 당업계에 공지된 방법을 이용하여 각종 공지의 성분 등을 추가하여 화장수, 로션, 크림, 에센스, 팩, 파우더, 메이컵베이스, 파운데이션, 바디오일, 바디로션, 클렌징오일, 클렌징폼, 헤어오일, 헤어샴프 및 헤어린스, 비누 중에서 선택된 어느 하나의 제형으로 제조될 수 있다. The cosmetic composition of the present invention is prepared by adding various known ingredients using a method known in the art to make lotion, lotion, cream, essence, pack, powder, makeup base, foundation, body oil, body lotion, cleansing oil, It may be prepared in any one formulation selected from cleansing foam, hair oil, hair shampoo and hair rinse, and soap.
구체적으로 본 발명의 화장료 조성물의 제형이 페이스트, 크림 또는 겔, 팩인 경우 공지의 성분으로서 동물섬유, 식물섬유, 왁스, 파라핀, 전분, 트라가칸트, 셀롤로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등이 이용될 수 있다. Specifically, when the formulation of the cosmetic composition of the present invention is a paste, cream, gel, or pack, animal fibers, vegetable fibers, wax, paraffin, starch, tragacanth, cellulose derivatives, polyethylene glycol, silicone, bentonite, Silica, talc or zinc oxide or the like may be used.
본 발명의 화장료 조성물의 제형이 파우더인 경우 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더 등이 이용될 수 있다.When the formulation of the cosmetic composition of the present invention is a powder, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used.
본 발명의 화장료 조성물의 제형이 용액 또는 유탁액인 경우 용매, 용매화제 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 이소프로판올, 에틸 카보네이트, 에틸 아세테이트, 벤질알코올, 벤질 벤조에이트, 프로필렌 글리콜, 1,3-부틸글리콜 오일, 글리세롤 지방족 에스테르, 폴리에틸렌글리콜 또는 소르비탄의 비방산 에스테르 등이 이용될 수 있다. When the formulation of the cosmetic composition of the present invention is a solution or emulsion, a solvent, solvating agent or emulsifying agent is used, such as water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, benzyl benzoate, propylene glycol, 1, 3-butyl glycol oil, glycerol aliphatic ester, polyethylene glycol, or non-radiative acid ester of sorbitan may be used.
본 발명의 화장료 조성물의 제형이 현탁액인 경우 물, 에탄올 또는 프로필렌글리콜과 같은 액상 희석제, 에톡실화이소스테아릴알코올, 폴리옥시에틸렌 스르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀롤로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라가칸트 등이 이용될 수 있다.When the formulation of the cosmetic composition of the present invention is a suspension, a liquid diluent such as water, ethanol or propylene glycol, a suspending agent such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, microcrystalline Cellulose, aluminum metahydroxide, bentonite, agar or tragacanth and the like may be used.
본 발명의 화장료 조성물의 제형이 계면활성제 함유 세정제인 경우 지방족 알코올 설페이트, 지방족 알코올 에테르 설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성유 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다.When the formulation of the cosmetic composition of the present invention is a surfactant-containing detergent, aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyl taurate, sarcosinate, fatty acid amide ether sulfate , Alkylamidobetaine, aliphatic alcohol, fatty acid glyceride, fatty acid diethanolamide, vegetable oil or ethoxylated glycerol fatty acid ester, etc. may be used.
본 발명의 화장료 조성물의 제형이 에센스일 경우 허브워터, 점증제, 아데노신, 보습제, 히알루론산, 트레할로스, 스쿠알란, 방부제, 에센셜오일 등이 이용될 수 있다. If the formulation of the cosmetic composition of the present invention is an essence, herb water, thickener, adenosine, moisturizer, hyaluronic acid, trehalose, squalane, preservatives, essential oil and the like may be used.
이 외에도 본 발명의 화장료 조성물은 통상적인 공지된 성분인 안정화제, 용해화제, 비타민, 안료 및 향료 등이 이용할 수 있으며, 당업계에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있고, 사용 대상에 따라 적절하게 선택될 수 있다. In addition, the cosmetic composition of the present invention can use conventionally known ingredients such as stabilizers, solubilizers, vitamins, pigments, and fragrances, and can be prepared in any formulation conventionally prepared in the art, can be selected appropriately.
제형의 일 예로 화장수는 에탄올 1.5중량%, 내추럴 리퀴드 1.0중량%, 베타인 3.0중량%, 디엘 판테놀 3.0중량%, 세붐-A 1.0중량%, 알부틴 페이스트 2.0중량%, 아네노신 2.0중량%, 에코검 0.03중량%, 글리세린 4.0중량%, 콜라겐 1.0중량%, 복합추출물 10.0중량%, 방부제(미량), 정제수(잔량)로 조성될 수 있다.As an example of the formulation, the toner contains 1.5% by weight of ethanol, 1.0% by weight of natural liquid, 3.0% by weight of betaine, 3.0% by weight of DL Panthenol, 1.0% by weight of Sebum-A, 2.0% by weight of arbutin paste, 2.0% by weight of anenosine, and eco gum. It may be composed of 0.03% by weight, 4.0% by weight of glycerin, 1.0% by weight of collagen, 10.0% by weight of complex extract, preservatives (a small amount), and purified water (remaining amount).
또한, 제형의 일 예로 로션은 카보머 1.0중량%, 디메치콘 2.0중량%, 호호바 오일 5.0중량%, 프로비타민E 0.5중량%, 올리브 유화왁스 1.0중량%, 알부틴 페이스트 5.0중량%, T-믹스처 1.2중량%, 폼믹스처 1.0중량%, 바타인1.0중량%, 세테아릴알코올 1.5중량%, 글리세린 4.0중량%, 플렉스오일 5.0중량%, 알부틴 페이스트 5.0중량%, 복합추출물 10.0중량%, 블랜딩 에센스 오일(미량), 방부제(미량), 정제수(잔량)로 조성될 수 있다.In addition, as an example of the formulation, the lotion contains carbomer 1.0% by weight, dimethicone 2.0% by weight, jojoba oil 5.0% by weight, provitamin E 0.5% by weight, olive emulsifying wax 1.0% by weight, arbutin paste 5.0% by weight, T-Mixture 1.2% by weight, foam mixture 1.0% by weight, bartain 1.0% by weight, cetearyl alcohol 1.5% by weight, glycerin 4.0% by weight, flex oil 5.0% by weight, arbutin paste 5.0% by weight, complex extract 10.0% by weight, blending essence It can be composed of oil (trace amount), preservative (trace amount), and purified water (remaining amount).
또한, 제형의 일 예로 크림은 세테아릴알코올 1.5중량%, 글리세릴스테아레이트 1.0중량%, 폴리소르베이트60 1.0중량%, 소르비탄세스퀴올리에이트 0.3중량%, 세틸옥타노에이트 6.0중량%, 스쿠알란 8.0중량%, 아프리코드커넬오일 4.0중량%,디메치콘 2.0중량%, 부틸렌글라이콜 4.0중량%, 글리세린 4.0중량%, 마그네슘알루미늄실리케이트0.4중량%, 복합추출물 10.0중량%, 블랜딩 에센스 오일(미량), 방부제(미량), 정제수(잔량)로 조성될 수 있다.In addition, as an example of the formulation, the cream contains 1.5% by weight of cetearyl alcohol, 1.0% by weight of glyceryl stearate, 1.0% by weight of
또한, 제형의 일 예로 에센스는 에탄올 1.5중량%, 내추럴 리퀴드 1.0중량%, 카보머 1.0중량%, 베타인 3.0중량%, 아데노신 2.0중량%, 알부틴 페이스트 5.0중량%, 히알루론산나트륨수용액(1%) 0.03중량%, 디엘 판테놀 3.0중량%, 글리세린 4.0중량%, 세붐-A 1.0중량%, 복합추출물 10.0중량%, 블랜딩 에센스 오일(미량), 방부제(미량), 정제수(잔량)로 조성될 수 있다.In addition, as an example of the formulation, the essence is ethanol 1.5% by weight, natural liquid 1.0% by weight, carbomer 1.0% by weight, betaine 3.0% by weight, adenosine 2.0% by weight, arbutin paste 5.0% by weight, sodium hyaluronate aqueous solution (1%) 0.03% by weight, DL Panthenol 3.0% by weight, glycerin 4.0% by weight, Sebum-A 1.0% by weight, complex extract 10.0% by weight, blending essence oil (trace amount), preservative (trace amount), purified water (remaining amount).
또한, 제형의 일 예로 파운데이션은 스테아릭애씨드 2.0중량%, 세테아릴알코올 0.5중량%, 글리세릴스테아레이트 1.0중량%, 폴리소르베이트60 0.5중량%, 소르비탄세스퀴올리에이트 0.7중량%, 하이드로제네이티드랩씨드오일 2.0중량%, 해바라기유 5.0중량%, 스쿠알란 6.0중량%, 세틸옥타노에이트 4.0중량%, 사이클로메치콘 2.0중량%, 부틸렌글라이콜 5.0중량%, 글리세린 3.0중량%, 마그네슘알루미늄실리케이트 0.6중량%, 산탄검 0.05중량%, 이산화티탄 10.0중량%, 탈크 3.0중량%, 하이드레이티드페릭옥사이드 1.3중량%, 페릭옥사이드 0.3중량%, 페러스-페릭옥사이드 0.15중량%, 복합추출물 10.0중량%, 방부제(미량), 정제수(잔량)로 조성될 수 있다.In addition, as an example of the formulation, the foundation contains 2.0% by weight of stearic acid, 0.5% by weight of cetearyl alcohol, 1.0% by weight of glyceryl stearate, 0.5% by weight of
또한, 제형의 일 예로 팩은 프로필렌글리콜 0.5중량%, 내추럴 리퀴드 1.0중량%, 폴리비닐알코올 3.0중량%, 에탄올 3.0중량%, 카보머 1.0중량%, 콜라겐 2.0중량%, 에코검 1.0중량%, 펩타이드RF 1.0중량%, 디엘 판테놀 3.0중량%, 글리세린 4.0중량%, 세붐-A 1.0중량%, 아데노신 2.0중량%, 복합추출물 10.0중량%, 블랜딩 에센스 오일(미량), 방부제(미량), 정제수(잔량)로 조성될 수 있다.In addition, as an example of the formulation, the pack contains 0.5% by weight of propylene glycol, 1.0% by weight of natural liquid, 3.0% by weight of polyvinyl alcohol, 3.0% by weight of ethanol, 1.0% by weight of carbomer, 2.0% by weight of collagen, 1.0% by weight of eco gum, and peptides. RF 1.0 wt%, DL Panthenol 3.0 wt%, Glycerin 4.0 wt%, Sebum-A 1.0 wt%, Adenosine 2.0 wt%, Complex Extract 10.0 wt%, blending essence oil (trace amount), preservative (trace amount), purified water (remaining amount) can be composed of
또한, 제형의 일 예로 헤어샴푸는 폴리 쿼터니움 0.5중량%, 내추럴 리퀴드 1.0중량%, 코카미도 프로필베타인3.0중량%, 베타인 3.0중량%, CDA 7.0중량%, LES 25.0중량%, 코코베테인 5.0중량%, 콜라겐 1.0중량%, 디엘 판테놀 3.0중량%, 글리세린 4.0중량%, 세붐-A 1.0중량%, 아데노신 2.0중량%, 복합추출물 10.0중량%, 블랜딩 에센스 오일(미량), 방부제(미량), 정제수(잔량)로 조성될 수 있다.In addition, as an example of the formulation, the hair shampoo contains 0.5% by weight of polyquaternium, 1.0% by weight of natural liquid, 3.0% by weight of cocamido propyl betaine, 3.0% by weight of betaine, 7.0% by weight of CDA, 25.0% by weight of LES, and cocobetaine. 5.0% by weight, collagen 1.0% by weight, DL Panthenol 3.0% by weight, glycerin 4.0% by weight, Sebum-A 1.0% by weight, adenosine 2.0% by weight, complex extract 10.0% by weight, blending essence oil (trace amount), preservative (trace amount), It can be composed of purified water (remaining amount).
또한, 제형의 일 예로 비누는 복합추출물 10.0중량%, 글리세린 2.0중량%, 에션셀 오일 1.0중량%, 지방산을 비누화시키 비누베이스(잔량)로 조성될 수 있다. In addition, as an example of the formulation, the soap may be composed of 10.0% by weight of the complex extract, 2.0% by weight of glycerin, 1.0% by weight of essence cell oil, and a soap base (remaining amount) obtained by saponifying fatty acids.
한편, 본 발명은 다른 예로 복합추출물과 함께 지채 발효추출물을 함유할 수 있다. 이 경우 복합추출물 100중량부에 대하여 지채 발효추출물 2 내지 30중량부를 혼합할 수 있다. On the other hand, the present invention may contain a fermented zucchini extract together with a complex extract as another example. In this case, 2 to 30 parts by weight of the fermented zucchini extract may be mixed with respect to 100 parts by weight of the complex extract.
지채 발효추출물은 지채를 발효시킨 후 추출하여 수득할 수 있다. 지채(Triglochin maritimum L.)는 지채과에 속하는 다년생 초본으로서, 주로 해안의 갯벌에서 자란다. Jichae fermentation extract can be obtained by extracting after fermenting Jichae. Triglochin maritimum L. is a perennial herb belonging to the Triglochinaceae family and grows mainly in coastal tidal flats.
지채는 전체 부위를 이용하거나 잎만을 이용할 수 있다. 지채를 발효시키기 위한 방법으로서, 지채 100중량부에 대하여 설탕 20 내지 50중량부를 혼합하고 발효균주 0.01 내지 1.0중량부를 첨가한 후 20 내지 40℃에서 20 내지 60일 동안 발효시킨다. 발효균주로 사카로미세스 속 균주를 이용할 수 있다. 사카로미세스 속 균주로 사카로미세스 루시(Saccharomyces rouxii), 사카로미세스 세레비시아에(Saccharomyces cereviciae), 사카로미세스 오비폴미스(Saccharomyces oviformis), 사카로미세스 스테이네리(Saccharomyces steineri) 등을 들 수 있다. 효모균으로 시판중인 건조효모제품을 이용할 수 있다.The whole part or only the leaves can be used for the support. As a method for fermenting the ground, 20 to 50 parts by weight of sugar is mixed with respect to 100 parts by weight of the ground, 0.01 to 1.0 parts by weight of the fermentation strain is added, and then fermented at 20 to 40 ° C. for 20 to 60 days. A strain of the genus Saccharomyces may be used as a fermentation strain. Examples of Saccharomyces genus strains include Saccharomyces rouxii , Saccharomyces cerevisiae , Saccharomyces oviformis , Saccharomyces steineri and the like. can Commercially available dried yeast products can be used as yeast.
발효가 완료되면 발효물에 물을 가해 지채 발효추출물을 추출한다. 추출의 일 예로 저온에서 진공추출하는 방법을 이용할 수 있다. 가령, 진공저온추출기에 물 100중량부에 대하여 발효물 10 내지 50중량부를 투입한 후 진공(100 내지 200torr) 조건하에서 60 내지 80℃로 4 내지 10시간 동안 진공추출한다. 진공저온추출 후 여과하여 지채 발효추출물을 얻을 수 있다.When fermentation is complete, water is added to the fermented product to extract the fermented zucchini extract. As an example of extraction, a method of vacuum extraction at low temperature may be used. For example, 10 to 50 parts by weight of fermented material is added to a vacuum low-temperature extractor based on 100 parts by weight of water, and then vacuum extraction is performed at 60 to 80 ° C. for 4 to 10 hours under vacuum (100 to 200 torr) conditions. After vacuum low-temperature extraction, it can be filtered to obtain a fermented zucchini extract.
이와 같이 수득한 지채 발효추출물은 항산화 및 항균활성이 우수하여 화장료 조성물의 기능성을 높일 수 있다. 특히 지채 발효추출물은 복합추출물과 더해져 복합추출물의 효과를 상승시킬 것으로 기대된다. The fermented zucchini extract obtained in this way has excellent antioxidant and antibacterial activity, so that the functionality of the cosmetic composition can be improved. In particular, it is expected that the fermented extract of jjichae will be added to the complex extract to increase the effect of the complex extract.
지채 발효추출물을 함유할 경우, 본 발명의 화장료 조성물은 전체 총 중량에서 복합추출물을 0.01 내지 20중량%, 지채 발효추출물 0.1 내지 5중량%를 함유할 수 있다. When containing the fermented zucchini extract, the cosmetic composition of the present invention may contain 0.01 to 20% by weight of the complex extract and 0.1 to 5% by weight of the fermented zucchini extract based on the total total weight.
이하, 본 발명의 내용을 하기의 실시예 및 실험을 통하여 구체적으로 설명한다. 이는 본 발명을 보다 상세하게 설명하기 위한 것으로, 본 발명의 권리 범위를 하기의 실시예로 한정하는 것은 아니다.Hereinafter, the contents of the present invention will be specifically described through the following examples and experiments. This is for explaining the present invention in more detail, and the scope of the present invention is not limited to the following examples.
(실시 예: 복합추출물 추출)(Example: Complex extract extraction)
-프로폴리스 500g에 농도 20%(w/w)의 에탄올 2L를 넣고 50rpm, 35℃에서 5일간 추출한 후 여과하여 프로폴리스 추출물을 준비하였다. - Propolis extract was prepared by adding 2L of 20% (w/w) ethanol to 500 g of propolis, extracting at 50 rpm and 35 ° C for 5 days, and then filtering.
-보스웰리아 500g을 물로 수세한 후 농도 20%(w/w)의 에탄올 2L를 넣고 50rpm, 35℃에서 5일간 추출한 후 여과하여 보스웰리아 추출물을 준비하였다. - Wash 500g of Boswellia with water, add 2L of 20% (w/w) ethanol, extract at 50rpm and 35°C for 5 days, and then filter to prepare Boswellia extract.
-배 열매 500g을 물로 수세한 후 농도 20%(w/w)의 에탄올 2L를 넣고 50rpm, 35℃에서 5일간 추출한 후 여과하여 배 추출물을 준비하였다. - After washing 500g of pear fruit with water, 2L of 20% (w/w) ethanol was added, extracted at 50 rpm and 35 ° C for 5 days, and then filtered to prepare a pear extract.
-오배자 500g을 물로 수세한 후 20% 발효주정 2L를 넣고 50rpm, 35℃에서 5일간 추출한 후 여과하여 오배자 추출물을 준비하였다. -After washing 500g of nut gall with water, 2L of 20% fermented alcohol was added, extracted at 50 rpm and 35 ° C for 5 days, and filtered to prepare nut gall extract.
-파인애플은 열매 껍질을 제거한 과육 500g에 농도 20%(w/w)의 에탄올 2L를 넣고 50rpm, 35℃에서 5일간 추출한 후 여과하여 파인애플 추출물을 준비하였다. -Pineapple extract was prepared by adding 2L of 20% (w/w) ethanol to 500g of fruit pulp from which the fruit skin was removed, extracting at 50rpm and 35℃ for 5 days, and then filtering.
-참다래 열매 500g을 물로 수세한 후 농도 20%(w/w)의 에탄올 2L를 넣고 50rpm, 35℃에서 5일간 추출한 후 여과하여 참다래 추출물을 준비하였다. -After washing 500g of kiwifruit fruit with water, 2L of 20% (w/w) ethanol was added, extracted at 50 rpm and 35℃ for 5 days, and then filtered to prepare an extract of kiwifruit.
각 추출물은 하기 표 1의 비율로 혼합하여 6종류의 복합추출물(No.1~6)을 수득하였다. 그리고 이와 비교하기 위하여 추출물로서 프로폴리스 단독 추출물(No.7)과 프로폴리스 추출물과 오배자 추출물을 동일 중량비로 혼합한 추출물(No.8)을 이용하였다. Each extract was mixed in the ratio shown in Table 1 below to obtain 6 types of composite extracts (No.1 to 6). And for comparison, a propolis alone extract (No.7) and an extract (No.8) obtained by mixing propolis extract and nut gall extract at the same weight ratio were used as extracts.
추출물(g)propolis
extract (g)
추출물(g)gallnut
extract (g)
추출물(g)boswellia
extract (g)
추출물(g)pineapple
extract (g)
추출물(g)kiwifruit
extract (g)
추출물(g)ship
extract (g)
No.1~8의 추출물은 45±2℃ 암실에서 3일간 숙성한 후 여과지로 여과한 다음 동결건조시켜 분말 형태로 제조한 후 시료로 이용하였다. 각 시료는 25, 50, 100, 200μg/ml의 농도로 희석하여 사용하였다. The extracts of No. 1 to 8 were aged for 3 days at 45 ± 2 ° C in the dark, filtered with filter paper, lyophilized, prepared in powder form, and used as samples. Each sample was diluted to a concentration of 25, 50, 100, or 200 μg/ml.
<실험예><Experimental example>
1. 항산화활성 실험1. Antioxidant activity test
항산화테스트는 DPPH assay와 ABTS assay를 통해 진행하였다. Antioxidant test was conducted through DPPH assay and ABTS assay.
DPPH(1,1-diphenyl-2-picryl-hydrazyl) assay를 이용하여 자유 라디칼(free radical) 소거활성능을 측정한 결과를 도 1에 나타내었다. 양성대조군으로 BHA(butylated hydroxyl anisol)를 사용하였다. The results of measuring the free radical scavenging activity using DPPH (1,1-diphenyl-2-picryl-hydrazyl) assay are shown in FIG. 1 . BHA (butylated hydroxyl anisol) was used as a positive control.
도 1을 참조하면, 복합추출물 1, 2번이 프로폴리스를 단독으로 사용한 7번보다 높게 나타났으며, 특히 2번 복합추출물에서 가장 높은 항산화 활성을 나타냈다.Referring to Figure 1, complex extracts No. 1 and No. 2 were higher than No. 7 using propolis alone, and in particular, complex extract No. 2 showed the highest antioxidant activity.
ABTS(2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid))를 사용한 항산화 시험결과를 도 2에 나타내었다. 양성대조군으로 BHA(butylated hydroxyl anisol)를 사용하였다. Antioxidant test results using ABTS (2,2'-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)) are shown in FIG. 2 . BHA (butylated hydroxyl anisol) was used as a positive control.
도 2를 참조하면, DPPH 방법을 통해 확인한 것과 유사한 패턴으로 나왔으면 2번 복합추출물에서 가장 높은 활성을 나타냈다.Referring to Figure 2, if it came out in a pattern similar to that confirmed through the DPPH method showed the highest activity in the composite extract No. 2.
2. 미백활성 실험2. Whitening activity test
화장품의 원료로서의 효능을 알아보기 위하여 미백관련 활성을 측정하였다. 미백관련 활성은 Tyrosinase inhibition activity assay(L-DOPA oxidation inhibition activity assay)로 진행하였다. In order to find out the efficacy as a raw material for cosmetics, the activity related to whitening was measured. Whitening-related activity was performed by Tyrosinase inhibition activity assay (L-DOPA oxidation inhibition activity assay).
티로시나아제(tyrosinase) 저해활성 측정은 버섯 티로시나아제(mushroom tyrosinase)와 기질인 L-DOPA를 사용하였다. 반응구는 0.175M sodium phosphate buffer(pH 6.8) 0.5mL에 10mM L-DOPA를 녹인 기질액 0.2mL 및 복합추출물 또는 양성 대조군으로서 알부틴을 사용하였다. 혼합액에 버섯 티로시나아제(110U/mL) 0.2 mL을 첨가하여 25℃에서 2분간 반응시켜 반응액 중에 생성된 DOPA chrome을 475nm에서 흡광도를 측정하였으며, 티로시나아제 저해활성은 복합추출물 또는 알부틴의 첨가구와 무첨가구의 흡광도 감소율로 나타내었다. 실험결과를 도 3에 나타내었다. To measure tyrosinase inhibitory activity, mushroom tyrosinase and substrate L-DOPA were used. For the reaction zone, 0.2 mL of a substrate solution obtained by dissolving 10 mM L-DOPA in 0.5 mL of 0.175 M sodium phosphate buffer (pH 6.8) and arbutin were used as a composite extract or positive control. 0.2 mL of mushroom tyrosinase (110 U/mL) was added to the mixed solution and reacted at 25 ° C for 2 minutes. The absorbance of DOPA chrome generated in the reaction solution was measured at 475 nm. It was expressed as the rate of decrease in absorbance between the sphere and the non-additive sphere. The experimental results are shown in FIG. 3 .
도 3을 참조하면, 복합추출물의 미백활성 실험결과는 위의 항산화 활성 실험결과와 유사한 패턴으로 나타났다. 복합추출물인 2번에서 가장 높은 활성을 나타냈다.Referring to Figure 3, the whitening activity test results of the composite extract showed a pattern similar to the above antioxidant activity test results. Complex extract No. 2 showed the highest activity.
복합추출물의 미백활성을 추가적으로 확인하기 위하여 1번부터 6번까지의 복합추출물을 대상으로 세포 내 멜라닌 함량 측정을 통해 melanocyte 내에서의 melanin 생성량을 알아보았다. 1×105개의 B16/F10 cell을 cell culture dish에 분주하여 24시간 동안 배양하고 3일 간의 시료 처리 후 배양 세포를 1×phosphate buffered saline(PBS)으로 씻어준 다음 10% dimethyl sulfoxide(DMSO)가 포함된 1 N sodium hydroxide(NaOH) 용액을 처리하여 80℃에서 한 시간 동안 반응시킨 후 multi-plate reader를 이용하여 475nm에서 흡광도를 측정하였다. 전체 단백질량을 측정한 후 일정 단백질량당 멜라닌량을 계산하였다. In order to further confirm the whitening activity of the complex extract, the amount of melanin produced in melanocytes was measured by measuring the intracellular melanin content of the complex extracts from No. 1 to No. 6. 1 × 10 5 B16/F10 cells were dispensed into a cell culture dish and cultured for 24 hours. After sample treatment for 3 days, the cultured cells were washed with 1 × phosphate buffered saline (PBS) and then mixed with 10% dimethyl sulfoxide (DMSO). After treating the included 1 N sodium hydroxide (NaOH) solution and reacting at 80 ° C for one hour, the absorbance was measured at 475 nm using a multi-plate reader. After measuring the total amount of protein, the amount of melanin per certain amount of protein was calculated.
세포내 멜라닌 생성을 촉진하기 위하여 α-MSH(Alpha-Melanocyte-stimulating hormone)를 처리하였고, 양성대조군으로 Arb(알부틴)을 처리하여 비교하였다. 실험결과를 도 4에 나타내었다. α-MSH (Alpha-Melanocyte-stimulating hormone) was treated to promote intracellular melanin production, and Arb (arbutin) was treated and compared as a positive control. The experimental results are shown in FIG. 4 .
도 4를 참조하면, 복합추출물은 전반적으로 세포내 멜라닌 합성을 저해하는 것으로 나타났으며, 그 중에서 2번 복합추출물에서 가장 뛰어난 효능이 나타났다.Referring to Figure 4, the composite extract was found to inhibit intracellular melanin synthesis as a whole, showed the most excellent efficacy in the composite extract No. 2 among them.
3. 세포독성 실험3. Cytotoxicity test
1번부터 6번까지의 복합추출물을 대상으로 세포독성을 확인하기 위하여 MTT assay를 진행하였다. B16/F10(Mouse/Melanoma), Raw264.7(Mouse/Macrophage) 세포는 페니실린/스트렙토마이신(penicillin/streptomycin) 1%와 소 태아 혈청(fetal bovine serum) 10%가 함유된 DMEM배지를 사용하여 37℃, 5% CO2가 유지되는 항온기에서 배양하였다. 추출물의 세포에 대한 독성은 MTT(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay를 실시하였다. MTT는 담황색의 기질로서, 살아있는 세포의 미토콘드리아 내 효소와 반응하여 포르마잔(Formazan)을 형성하는데, 이 포르마잔을 다이메틸설폭사이드(DMSO; Dimethyl sulfoxide)에 녹여 570nm의 흡광도를 측정함으로써 세포의 생존율을 측정하였다.MTT assay was performed to confirm the cytotoxicity of the composite extracts from No. 1 to No. 6. B16/F10 (Mouse/Melanoma) and Raw264.7 (Mouse/Macrophage) cells were cultured in DMEM medium containing 1% penicillin/streptomycin and 10% fetal bovine serum. ℃, 5% CO 2 It was cultured in an incubator maintained. Toxicity of the extract to cells was evaluated by MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay. MTT is a pale yellow substrate that reacts with enzymes in the mitochondria of living cells to form formazan. By dissolving this formazan in dimethyl sulfoxide (DMSO) and measuring the absorbance at 570 nm, cell viability was determined. was measured.
B16/F10 세포에 대한 실험결과는 도 5에, Raw264.7 세포에 대한 실험결과는 도 6에 각각 나타내었다. The experimental results for B16/F10 cells are shown in FIG. 5 and the experimental results for Raw264.7 cells are shown in FIG. 6 , respectively.
도 5 및 도 6을 참조하면, 복합추출물의 처리농도 중 가장 높은 농도인 100μg/ml에서도 대부분은 90%이상의 생존률을 나타내 특별한 세포 독성은 보이지 않았다.5 and 6, even at the highest concentration of 100 μg / ml of the treatment concentration of the composite extract, most showed a survival rate of 90% or more, and no particular cytotoxicity was observed.
4. 주름개선 실험4. Wrinkle improvement experiment
복합추출물의 주름개선 활성을 알아보기 위하여 elastase inhibition assay를 통하여 주름개선 효능활성을 확인하였다. 기질로서 n-succinyl-(L-Ala)3-p-nitroanilide를 사용하여 37℃, 30분간 기질로부터 생성되는 p-nitroanilide의 생성량 측정하였다. 각 시료를 일정 농도(25,50,100μg/ml)가 되도록 조제하여 40㎕씩 96well plate에 취하고, 50mM Tris-HCl buffer(pH 8.6)에 녹인 2.5U/ml porcine pancreas elastase 용액을 40㎕를 가한다. 기질로 50mM Tris-HCl buffer(pH 8.6)에 녹인 n-succinyl-(L-Ala)3-pnitroanilide(0.5mg/ml)을 첨가하여 30분 간 반응시킨 후 5분간 얼음에 방치해 반응을 정지시킨 후 410nm에서 흡광도를 측정하였다. 주름개선 활성평가의 양성대조군으로는 Ursolic acid(U-A)를 사용하였다. In order to investigate the anti-wrinkle activity of the complex extract, the anti-wrinkle effect was confirmed through elastase inhibition assay. Using n-succinyl-(L-Ala)3-p-nitroanilide as a substrate, the amount of p-nitroanilide produced from the substrate was measured at 37°C for 30 minutes. Prepare each sample to a certain concentration (25, 50, 100 μg/ml), take 40 μl each in a 96-well plate, and add 40 μl of a 2.5 U/ml porcine pancreas elastase solution dissolved in 50 mM Tris-HCl buffer (pH 8.6). . As a substrate, n-succinyl-(L-Ala)3-pnitroanilide (0.5 mg/ml) dissolved in 50 mM Tris-HCl buffer (pH 8.6) was added, reacted for 30 minutes, and left on ice for 5 minutes to stop the reaction. After that, absorbance was measured at 410 nm. Ursolic acid (U-A) was used as a positive control for the wrinkle improvement activity evaluation.
실험결과를 도 7에 나타내었다. The experimental results are shown in FIG. 7 .
도 7을 참조하면, 비교 추출물인 7번과 8번에서도 다소 높은 활성을 나타냈지만, 복합추출물인 2번에서 가장 높은 활성을 나타냈다.Referring to FIG. 7, the comparative extracts No. 7 and No. 8 showed slightly higher activity, but the composite extract No. 2 showed the highest activity.
5. 항염실험5. Anti-inflammatory test
항염증능을 측정하기 위하여 Griess assay를 시행하였다. Raw264.7세포에 염증반응을 유도하기 위한 500ng/ml의 LPS를 처리한 후, 혼합 숙성 추출물을 농도별로 처리하여 24시간 배양한 후, 세포배양액 중 생성된 NO량을 그리스 시약(1% sulfanilamide, 0.1% naphylethylenediamine in 2.5% phosphoric aicd)를 이용하여 측정하였고, 그 결과를 도 8에 나타내었다.Griess assay was performed to measure anti-inflammatory activity. Raw264.7 cells were treated with 500 ng/ml of LPS to induce an inflammatory response, and mixed aged extracts were treated by concentration and cultured for 24 hours. 0.1% naphylethylenediamine in 2.5% phosphoric acid), and the results are shown in FIG. 8 .
도 8을 참조하면, Raw264.7세포에 LPS를 처리하였을 경우 염증반응이 유도가 되어 NO생성이 증가하는데 복합추출물을 처리하였을 경우 NO 생성량이 줄어드는 것을 확인하였다. 특히 2번 복합추출물에서 가장 높은 활성을 나타내는 것으로 나타났다.Referring to FIG. 8, when Raw264.7 cells were treated with LPS, an inflammatory reaction was induced to increase NO production, but it was confirmed that NO production was reduced when the composite extract was treated. In particular, it was found to show the highest activity in complex extract No. 2.
6. 항균활성 실험6. Antibacterial activity test
페이퍼 디스크법(paper disk diffusion method)을 통해 대장균(Escherichia coli), 황색포도상구균(Staphylococcus aureus), 녹농균(Pseudomonas aeruginosa), 프로피오니박테리움 아크네스(Propionibacterium acnes) 및 표피포도구균(Staphylococcus epidermidis)에 대한 항균 활성을 측정하였다. 항균 활성 실험결과를 하기 표 2에 나타내었다. Escherichia coli , Staphylococcus aureus, Pseudomonas aeruginosa , Propionibacterium acnes and Staphylococcus epidermidis by paper disk diffusion method Antibacterial activity against was measured. The antibacterial activity test results are shown in Table 2 below.
항균활성은 하기 표 2와 같이 생육저지환(clean jone)의 크기로 분류하였다.Antibacterial activity was classified according to the size of the clean jone as shown in Table 2 below.
항균활성 실험결과를 하기 표 3에 나타내었다. 대조군으로 방부제인 페녹시에탄올(PE)을 사용하였다. The antibacterial activity test results are shown in Table 3 below. As a control, phenoxyethanol (PE), a preservative, was used.
상기 표 3의 결과를 참조하면, 복합추출물 1~3번에 항균 활성이 나타났으며, 특히 2번에서 모든 균에 대해 항균활성이 높게 나타났다.Referring to the results of Table 3, antibacterial activity was shown in complex extracts 1 to 3, and in particular, antibacterial activity against all bacteria was high in No. 2.
<추가적 항산화 활성 실험><Additional antioxidant activity test>
위의 실험을 통해 효과가 가장 우수한 2번 복합추출물과 각 단독추출물(프로폴리스 추출물, 오배자 추출물, 보스웰리아 추출물, 파인애플 추출물, 참다래 추출물, 배 추출물)의 항산화 활성을 실험하였다. 실험결과를 도 9 및 도 10에 각각 나타내었다. 도 9 및 도 10에서 Pr:프로폴리스 추출물, Ga:오배자 추출물, Bo:보스웰리아 추출물, Pi:파인애플 추출물, Ki:참다래 추출물, Pe:배 추출물을 의미한다. Through the above experiment, the antioxidant activity of the No. 2 complex extract and each single extract (propolis extract, gall nut extract, boswellia extract, pineapple extract, kiwi extract, and pear extract), which had the highest effect, was tested. The experimental results are shown in FIGS. 9 and 10, respectively. 9 and 10, Pr: propolis extract, Ga: nut gall extract, Bo: boswellia extract, Pi: pineapple extract, Ki: kiwi extract, Pe: pear extract.
도 9를 참조하면, DPPH로 항산화활성을 확인한 결과 단독추출물보다 2번 복합추출물의 항산화 활성이 더 높게 나타났다. 그리고 도 10을 참조하면, ABTS로 항산화활성을 확인한 결과 단독추출물에 비해 2번 복합추출물의 항산화 활성이 더 높게 나타났다. Referring to Figure 9, as a result of confirming the antioxidant activity by DPPH, the antioxidant activity of the complex extract No. 2 was higher than that of the single extract. And referring to FIG. 10, as a result of confirming the antioxidant activity with ABTS, the antioxidant activity of the complex extract No. 2 was higher than that of the single extract.
위의 추가적인 항산화 활성 실험을 통해 프로폴리스 추출물, 오배자 추출물, 보스웰리아 추출물, 파인애플 추출물, 참다래 추출물, 배 추출물이 혼합될 경우 시너지 효과에 의해 항산화 활성이 크게 높아진 것을 확인할 수 있었다. Through the above additional antioxidant activity experiments, it was confirmed that the antioxidant activity was greatly increased by synergistic effect when propolis extract, gall nut extract, boswellia extract, pineapple extract, kiwi extract, and pear extract were mixed.
이상의 실험결과를 종합하여 볼때, 복합추출물은 항균, 항산화, 항염, 미백 및 주름 개선 효과가 우수한 것으로 나타났다. In view of the above experimental results, the complex extract was found to have excellent antibacterial, antioxidant, anti-inflammatory, whitening and anti-wrinkle effects.
<지채 발효추출물의 추출><Extraction of fermented vegetable extract>
전라남도 해안가에서 채취한 지채의 잎 100g에 대하여 설탕 40g을 혼합하고 발효균주로 사카로마이세스 세레비지에 0.2g를 첨가한 후 30℃에서 40일 동안 발효시켰다. 그리고 발효된 발효물에 물 300g을 가한 후 진공(150torr)하에서 70℃로 8시간 동안 진공추출하였다. 진공추출 후 여과지로 여과하여 지채 발효추출물을 얻었다. 40 g of sugar was mixed with 100 g of the leaves of the zucchini collected from the coast of Jeollanam-do, and 0.2 g of Saccharomyces cerevisiae was added as a fermentation strain, followed by fermentation at 30 ° C. for 40 days. After adding 300 g of water to the fermented product, vacuum extraction was performed at 70° C. for 8 hours under vacuum (150 torr). After vacuum extraction, the mixture was filtered with a filter paper to obtain a fermented zucchini extract.
2번 복합추출물과 지채 발효추출물을 4:1의 비율로 혼합하여 항균활성을 실험하였다. 그 결과를 하기 4에 나타내었다. The antibacterial activity was tested by mixing the complex extract of No. 2 and the fermented zucchini extract at a ratio of 4:1. The results are shown in 4 below.
상기 표 4의 결과를 참조하면, 2번 복합추출물에 지채 발효추출물이 혼합되면 항균활성이 높아지는 것으로 확인되었다. Referring to the results of Table 4 above, it was confirmed that the antibacterial activity was increased when the fermented vegetable extract was mixed with the complex extract No. 2.
(실시 예: 화장료 조성물 제조)(Example: Manufacturing cosmetic composition)
제 1에센스 샘플은 에탄올 1.5중량%, 내추럴 리퀴드 1.0중량%, 카보머 1.0중량%, 베타인 3.0중량%, 아데노신 2.0중량%, 알부틴 페이스트 5.0중량%, 히알루론산나트륨수용액 0.03중량%, 디엘 판테놀 3.0중량%, 글리세린 4.0중량%, 세붐-A 1.0중량%, 복합추출물 10.0중량%, 블랜딩 에센스 오일 0.4중량%, 정제수(잔량)로 조성하였다. The first essence sample contains 1.5% by weight of ethanol, 1.0% by weight of natural liquid, 1.0% by weight of carbomer, 3.0% by weight of betaine, 2.0% by weight of adenosine, 5.0% by weight of arbutin paste, 0.03% by weight of sodium hyaluronate aqueous solution, and 3.0% by weight of DL panthenol. It was composed of 4.0% by weight of glycerin, 1.0% by weight of Sebum-A, 10.0% by weight of complex extract, 0.4% by weight of blending essential oil, and purified water (remaining amount).
그리고 제 2에센스 샘플은 에탄올 1.5중량%, 내추럴 리퀴드 1.0중량%, 카보머 1.0중량%, 베타인 3.0중량%, 아데노신 2.0중량%, 알부틴 페이스트 5.0중량%, 히알루론산나트륨수용액 0.03중량%, 디엘 판테놀 3.0중량%, 글리세린 4.0중량%, 세붐-A 1.0중량%, 복합추출물 8.0중량%, 지채 발효추출물 2.0중량%, 블랜딩 에센스 오일 0.4중량%, 정제수(잔량)로 조성하였다.And the second essence sample contains 1.5% by weight of ethanol, 1.0% by weight of natural liquid, 1.0% by weight of carbomer, 3.0% by weight of betaine, 2.0% by weight of adenosine, 5.0% by weight of arbutin paste, 0.03% by weight of sodium hyaluronate aqueous solution, and DL panthenol. It was composed of 3.0% by weight, 4.0% by weight of glycerin, 1.0% by weight of Sebum-A, 8.0% by weight of complex extract, 2.0% by weight of fermented zucchini extract, 0.4% by weight of blending essential oil, and purified water (remaining amount).
피부 자극 정도를 알아보기 위해 제 1에센스샘플 및 제 2에센스샘플을 이용하여 피부 테스트를 실시하였다. 피부 테스트를 위해 피시험자의 등 부위에 에센스 샘플을 함유한 특수한 첩포(IQ chamber,Chemotechnique, Sweden)를 붙인 후 24시간이 경과하여 떼어내고 30분 후 판독하는 표준화된 안전성 평가방법인 24h single epicutaneous patch test로 수행하였다. 피부의 반응정도는 홍반, 부종, 가피 및 얕은 궤양 등에 관한 ICDRG(international contact dermatitis research group) 평가 기준표에 의해 1~4점으로 결정하여 총 평균값으로 기록하였다. 피부테스트 실험결과를 하기 표 5에 나타내었다.A skin test was conducted using the first essence sample and the second essence sample to determine the degree of skin irritation. 24h single epicutaneous patch, a standardized safety evaluation method in which a special patch (IQ chamber, Chemotechnique, Sweden) containing an essence sample is attached to the test subject's back for skin testing, then removed after 24 hours and read after 30 minutes performed as a test. The degree of response of the skin was determined as 1 to 4 points according to the ICDRG (international contact dermatitis research group) evaluation standard table for erythema, edema, scabs and shallow ulcers, and recorded as the total average value. The skin test results are shown in Table 5 below.
피부자극의 개연성은 평균평점기준으로 전체 피시험자의 20%에서 피부반응 2 이상의 반응이 있는 경우로 약 평균평점 45 이상인 경우이다(ICDRG score index 0~15: 피부 자극 없음, 15~25: 피부 자극이 없는 수준의 미약한 홍반, 25~45: 경미한 홍반과 부종으로 추가 확인시험 필요, >45:피부자극의 개연성이 있음).The probability of skin irritation is a case where 20% of the total test subjects had a skin reaction of 2 or higher based on the average score, and the average score was 45 or higher (ICDRG score index 0-15: no skin irritation, 15-25: skin irritation Mild erythema at a level without erythema, 25 to 45: Slight erythema and edema require additional confirmation tests, >45: Probability of skin irritation).
상기의 표 5의 결과로부터, 2종의 에센스 샘플들 모두 피시험자들에게 유의한 피부자극을 일으킬만한 홍반이나 부종반응을 나타내지 않은 것으로 확인되었다. 따라서 본 발명의 화장료 조성물은 피부에 자극 없이 안전하게 사용할 수 있음을 확인할 수 있었다.From the results of Table 5 above, it was confirmed that both types of essence samples did not show erythema or edema reactions that would cause significant skin irritation to the test subjects. Therefore, it was confirmed that the cosmetic composition of the present invention can be safely used without irritation to the skin.
이상, 본 발명은 일 실시 예를 참고로 설명되었으나 이는 예시적인 것에 불과하며, 당해 기술분야에서 통상의 지식을 가진 자라면 이로부터 다양한 변형 및 균등한 실시 예가 가능하다는 점을 이해할 것이다. 따라서 본 발명의 진정한 보호 범위는 첨부된 청구범위에 의해서만 정해져야 할 것이다.In the above, the present invention has been described with reference to one embodiment, but this is only exemplary, and those skilled in the art will understand that various modifications and equivalent embodiments are possible therefrom. Therefore, the true protection scope of the present invention should be defined only by the appended claims.
Claims (8)
상기 추출용매는 물, 탄소수 1 내지 4의 저급 알코올, 다가 알코올 또는 이들의 혼합물로부터 선택된 적어도 어느 하나인 것을 특징으로 하는 미백 및 주름개선 기능을 갖는 화장료 조성물. The method of claim 1, wherein each extract is extracted by adding an extraction solvent,
The extraction solvent is a cosmetic composition having a whitening and anti-wrinkle function, characterized in that at least one selected from water, lower alcohols having 1 to 4 carbon atoms, polyhydric alcohols, or mixtures thereof.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210152726A KR102630715B1 (en) | 2021-11-09 | 2021-11-09 | cosmetic composition for skin whitening and antiwrinkle |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020210152726A KR102630715B1 (en) | 2021-11-09 | 2021-11-09 | cosmetic composition for skin whitening and antiwrinkle |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20230067053A true KR20230067053A (en) | 2023-05-16 |
KR102630715B1 KR102630715B1 (en) | 2024-01-29 |
Family
ID=86545866
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020210152726A KR102630715B1 (en) | 2021-11-09 | 2021-11-09 | cosmetic composition for skin whitening and antiwrinkle |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102630715B1 (en) |
Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040078498A (en) * | 2003-03-04 | 2004-09-10 | 주식회사 코리아나화장품 | Cosmetic Composition for Enhancing Skin Elasticity Comprising Boswellia Extracts as Active Ingredient |
KR20090013293A (en) * | 2007-08-01 | 2009-02-05 | 안성마춤농협조합공동사업법인 | Anti-wrinkle cosmetic composition with anti-aging effect containing pear extracts |
KR20120102186A (en) * | 2011-03-08 | 2012-09-18 | 주식회사 코스메카코리아 | Cosmetics composite |
JP2014091717A (en) * | 2012-11-05 | 2014-05-19 | Ichimaru Pharcos Co Ltd | Melanogenesis inhibiting agent, moisturizer, whitening cosmetic, and cosmetic drink and food |
KR20180123831A (en) | 2017-05-10 | 2018-11-20 | 주식회사 더코스메디움 | Functional cosmetic composition and manufacturing method thereof |
KR20190093283A (en) | 2018-02-01 | 2019-08-09 | 청운대학교산학협력단 | Cosmetic composition composed of including extracts of drynaria fortunei and cosmetics using the same |
KR102021264B1 (en) | 2019-02-27 | 2019-09-19 | 재단법인 전남생물산업진흥원 | PHARMACEUTICAL COMPOSITION Porphyra dentata Kjellman EXTRACT FOR SKIN REGENERATION |
KR102282642B1 (en) * | 2021-01-19 | 2021-07-28 | (주)더마랩 | Cosmetic composition containing the extract of 5 aromatic herbs and 5 medicinal herb |
-
2021
- 2021-11-09 KR KR1020210152726A patent/KR102630715B1/en active IP Right Grant
Patent Citations (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20040078498A (en) * | 2003-03-04 | 2004-09-10 | 주식회사 코리아나화장품 | Cosmetic Composition for Enhancing Skin Elasticity Comprising Boswellia Extracts as Active Ingredient |
KR20090013293A (en) * | 2007-08-01 | 2009-02-05 | 안성마춤농협조합공동사업법인 | Anti-wrinkle cosmetic composition with anti-aging effect containing pear extracts |
KR20120102186A (en) * | 2011-03-08 | 2012-09-18 | 주식회사 코스메카코리아 | Cosmetics composite |
JP2014091717A (en) * | 2012-11-05 | 2014-05-19 | Ichimaru Pharcos Co Ltd | Melanogenesis inhibiting agent, moisturizer, whitening cosmetic, and cosmetic drink and food |
KR20180123831A (en) | 2017-05-10 | 2018-11-20 | 주식회사 더코스메디움 | Functional cosmetic composition and manufacturing method thereof |
KR20190093283A (en) | 2018-02-01 | 2019-08-09 | 청운대학교산학협력단 | Cosmetic composition composed of including extracts of drynaria fortunei and cosmetics using the same |
KR102021264B1 (en) | 2019-02-27 | 2019-09-19 | 재단법인 전남생물산업진흥원 | PHARMACEUTICAL COMPOSITION Porphyra dentata Kjellman EXTRACT FOR SKIN REGENERATION |
KR102282642B1 (en) * | 2021-01-19 | 2021-07-28 | (주)더마랩 | Cosmetic composition containing the extract of 5 aromatic herbs and 5 medicinal herb |
Also Published As
Publication number | Publication date |
---|---|
KR102630715B1 (en) | 2024-01-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Taofiq et al. | Mushrooms extracts and compounds in cosmetics, cosmeceuticals and nutricosmetics—A review | |
KR101971837B1 (en) | Cosmetic composition for improving skin whitening and wrinkle comprising adventitious root extract of Centella asiatica as effective component | |
US20160151273A1 (en) | Method for preparing cosmetic composition containing fermented ginseng berry pleurotus ferulae product and use thereof | |
KR20110108687A (en) | Skin whitening agent containing extracts of natural materials and composition of cosmetic | |
KR102349786B1 (en) | Cosmetic composition for anti-wrinkle and skin whitening | |
KR101825704B1 (en) | A cosmetic composition comprising coffee silver skin extract | |
KR101645476B1 (en) | Cosmetic Composition containing Fermentative Extract of Hippophae rhamnoides with Increased Amount of Vitamin C Fermented by Aureobasidium pullulans | |
KR101661545B1 (en) | Cosmetic composition comprising an extracts of fermented rhodiola rosea having whitening activits | |
KR20200134929A (en) | Cosmetic composition containing complex medicinal herbs extract for skin whitening and anti-wrinkle effect and manufacturing method thereof | |
KR101837020B1 (en) | Separation method for saponins from Sapindus mukorossi and cosmetic composition containing the same | |
KR102350857B1 (en) | Cosmetic composition containing lactic acid bacteria fermentation of chrysanthemum and magnolia extracted with YU SEONG hot spring water | |
KR102226179B1 (en) | Cosmetic Compositions for Anti-aging Comprising Extracts of Plants | |
KR101954275B1 (en) | Cosmetic compositions containing complex extract of gold kiwi peel and dragon fruit peel, and method manufacturing the same | |
KR102056263B1 (en) | A cosmetic composition comprising extract of coffee silver skin and coffee grounds | |
KR101552472B1 (en) | Method for producing Crassostrea gigas extract with increased antioxidant and whitening activity | |
KR20170136389A (en) | Composition for improving skin condition comprising herb extracts mixture | |
KR100295875B1 (en) | Cosmetics Containing Green Bean Extract | |
KR102630715B1 (en) | cosmetic composition for skin whitening and antiwrinkle | |
KR20140089305A (en) | Composition for improving skin whitening or skin wrinkle comprising extracts of Quercus salicina Blume | |
KR102075103B1 (en) | Cosmetic composition containing the fermented extract of okamejei kenojei | |
KR20180093560A (en) | A composition for skin whitening, anti-oxidating, astringent or anti-wrinkle comprising extracts of unripe plum | |
KR20130052288A (en) | Cosmetic composition comprising the hot spring water extract of nelumbo nucifera gaertner as active ingredient | |
KR20180082058A (en) | A cosmetic composition for skin desquamation comprising natural complex extract | |
KR101207560B1 (en) | Cosmetic composition comprising the extract of Cleyera japonica as active ingredient | |
KR20210027182A (en) | A composition comprising extract of Lilium hansonii |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |